Get the Stockscreener App
338.38
0.84%
-2.86
After Hours:
339.05
0.67
+0.20%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $338.38, with a volume of 1.61M.
It is down -0.84% in the last 24 hours and down -3.20% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$341.24
Open:
$340.72
24h Volume:
1.61M
Relative Volume:
0.78
Market Cap:
$129.59B
Revenue:
$25.12B
Net Income/Loss:
$3.25B
P/E Ratio:
40.29
EPS:
8.3984
Net Cash Flow:
$4.28B
1W Performance:
-0.22%
1M Performance:
-3.20%
6M Performance:
-8.36%
1Y Performance:
-2.39%
1-Day Range:
$336.52
$342.78
1-Week Range:
$336.52
$352.80
52-Week Range:
$319.32
$404.14
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
338.38 | 130.69B | 25.12B | 3.25B | 4.28B | 8.3984 |
ABT
Abbott Laboratories
|
95.47 | 176.48B | 44.33B | 6.50B | 7.40B | 3.717 |
MDT
Medtronic Plc
|
85.65 | 111.83B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
63.42 | 96.02B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
79.05 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Ambulatory Surgical Equipment Market to Reach USD 14.58 Billion, Rising at 7.85% by 2035 - GlobeNewswire Inc.
Stryker leads West Michigan public companies with $25.1B in revenue - Crain's Grand Rapids
Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK) - marketscreener.com
KBC Group NV Increases Position in Stryker Corporation $SYK - MarketBeat
Lbp Am Sa Has $84.59 Million Stake in Stryker Corporation $SYK - MarketBeat
Annex Advisory Services LLC Sells 15,163 Shares of Stryker Corporation $SYK - MarketBeat
US FDA Stryker updates use instructions for patient-fitted tmj implants - marketscreener.com
General Dynamics wins $44.4M contract modification for Stryker upgrades - Investing.com
Stryker Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Stryker Corp stock (US8636671013): Why its medtech leadership position matters more now for investor - AD HOC NEWS
Stryker (NYSE:SYK) Price Target Lowered to $380.00 at Truist Financial - MarketBeat
Stryker Cyberattack Has Impacted First Quarter Earnings - The HIPAA Journal
Stryker Corp. stock (US8636671013): Is its medtech moat strong enough to unlock new upside? - AD HOC NEWS
Stryker Corp stock (US8636671013): Why its medtech leadership matters more now for long-term investo - AD HOC NEWS
Stryker Corp. stock (US8636671013): Is medtech innovation strong enough to unlock new upside? - AD HOC NEWS
Ronda Stryker (SYK) updates 15.2M-share beneficial stake and recent trades - Stock Titan
Stryker's Q1 Results to See Material Impact From March Cybersecurity Incident, RBC Says - marketscreener.com
Stryker to Acquire AVS, Adding IVL Capabilities to Vascular Portfolio - Zacks Investment Research
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $397 to $435 - 富途牛牛
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
SYK Initiated by Leerink Partners -- Rating Set to Outperform - GuruFocus
Stryker (SYK) to Acquire Amplitude Vascular Systems - GuruFocus
Stryker agrees to buy Amplitude Vascular Systems for IVL tech - BioWorld News
Stryker (SYK) Expands Vascular Portfolio with Amplitude Vascular Acquisition - GuruFocus
Stryker to Acquire Amplitude Vascular Systems - Medical Product Outsourcing
Stryker (NYSE:SYK) Coverage Initiated by Analysts at Leerink Partners - MarketBeat
Leerink Partners Initiates Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $410 - 富途牛牛
Stryker to acquire vascular device maker Amplitude Vascular By Investing.com - Investing.com Canada
Stryker to acquire vascular device maker Amplitude Vascular - Investing.com
Stryker targets next-gen artery treatment with Amplitude deal - Stock Titan
‘Not a surprise’ Stryker didn’t renew local office space, experts say - Daily Memphian
SYK SEC FilingsStryker Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Stryker is fully operational after cyberattack - MedTech Dive
Stryker expects cyberattack to impact Q1 results - BioWorld News
Stryker (SYK) Confident in 2026 Guidance Despite Cybersecurity I - GuruFocus
Stryker confident of 2026 outlook despite Q1 impact from cyberattack - Seeking Alpha
Truist reiterates Hold on Stryker stock after cyberattack update - Investing.com
Piper Sandler Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $420 - Moomoo
Stryker Corporation Discloses Material Cybersecurity Incident in March 2026 8-K/A Filing - Minichart
[8-K/A] STRYKER CORP Amends Material Event Report - Stock Titan
Goldman Sachs Lowers Stryker (SYK) Price Target Amid Neutral Rat - GuruFocus
Jackson Square Capital LLC Sells 4,712 Shares of Stryker Corporation $SYK - MarketBeat
CCLA Investment Management Boosts Stake in Stryker Corporation $SYK - MarketBeat
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com
Stryker Corp. stock rises Wednesday, still underperforms market - MarketWatch
Goldman Sachs Adjusts Stryker Price Target to $357 From $403, Maintains Neutral Rating - Moomoo
Stryker Corporation $SYK Shares Sold by Greenleaf Trust - MarketBeat
Citi Adjusts Stryker (SYK) Target Price Amid Cybersecurity Conce - GuruFocus
Citi Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $385 - 富途牛牛
Stock Yards Bank & Trust Co. Sells 32,355 Shares of Stryker Corporation $SYK - MarketBeat
Evercore ISI Group Maintains Stryker (SYK) with Lowered Price Ta - GuruFocus
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):